135 related articles for article (PubMed ID: 31903905)
1. [CRISPR-Cas9 editing of HIV-1 neutralizing human B cells].
Beretta M; Mouquet H
Med Sci (Paris); 2019 Dec; 35(12):993-996. PubMed ID: 31903905
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells.
Laoharawee K; Johnson MJ; Moriarity BS
Methods Mol Biol; 2020; 2115():435-444. PubMed ID: 32006415
[TBL] [Abstract][Full Text] [Related]
3. HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells.
Hartweger H; McGuire AT; Horning M; Taylor JJ; Dosenovic P; Yost D; Gazumyan A; Seaman MS; Stamatatos L; Jankovic M; Nussenzweig MC
J Exp Med; 2019 Jun; 216(6):1301-1310. PubMed ID: 30975893
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
5. Natural evolution of broadly neutralizing antibodies.
Alter G; Barouch DH
Cell; 2015 Apr; 161(3):427-428. PubMed ID: 25910199
[TBL] [Abstract][Full Text] [Related]
6. Gene Editing for HIV Cure at the Edge.
Soriano V
AIDS Rev; 2019; 21(1):50a-51. PubMed ID: 30899116
[No Abstract] [Full Text] [Related]
7. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
8. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection.
Deng Q; Chen Z; Shi L; Lin H
Rev Med Virol; 2018 Sep; 28(5):e1998. PubMed ID: 30024073
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming the antigen specificity of B cells using genome-editing technologies.
Voss JE; Gonzalez-Martin A; Andrabi R; Fuller RP; Murrell B; McCoy LE; Porter K; Huang D; Li W; Sok D; Le K; Briney B; Chateau M; Rogers G; Hangartner L; Feeney AJ; Nemazee D; Cannon P; Burton DR
Elife; 2019 Jan; 8():. PubMed ID: 30648968
[TBL] [Abstract][Full Text] [Related]
11. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.
Henderson LJ; Reoma LB; Kovacs JA; Nath A
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694954
[TBL] [Abstract][Full Text] [Related]
12. Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.
Yin Y; Reed EF; Zhang Q
Sci Rep; 2019 May; 9(1):8067. PubMed ID: 31147565
[TBL] [Abstract][Full Text] [Related]
13. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Kuruvilla J; Sasmita AO; Ling APK
Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
[TBL] [Abstract][Full Text] [Related]
15. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
16. A Single Transcript CRISPR-Cas9 System for Efficient Genome Editing in Plants.
Tang X; Zheng X; Qi Y; Zhang D; Cheng Y; Tang A; Voytas DF; Zhang Y
Mol Plant; 2016 Jul; 9(7):1088-91. PubMed ID: 27212389
[No Abstract] [Full Text] [Related]
17. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
18. Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus.
Ahmad M; Ahmed OM; Schnepp B; Johnson PR
Annu Rev Virol; 2017 Sep; 4(1):491-510. PubMed ID: 28645240
[TBL] [Abstract][Full Text] [Related]
19. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
